{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T05:22:39Z","timestamp":1669094559371},"reference-count":31,"publisher":"Hogrefe Publishing Group","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Praxis"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p> R\u00e9sum\u00e9. La pand\u00e9mie COVID-19 repr\u00e9sente un probl\u00e8me de sant\u00e9 publique majeur. Une partie de la population est \u00e0 risque accru de d\u00e9velopper des complications de cette maladie, en particulier les personnes \u00e2g\u00e9es ainsi que les malades diab\u00e9tiques, les ob\u00e8ses et, possiblement, les malades hypertendus. Pour ces derniers, cela reste \u00e0 \u00eatre confirm\u00e9 dans des \u00e9tudes contr\u00f4l\u00e9es de grande envergure. Les connaissances accumul\u00e9es \u00e0 ce jour sont rassurantes, que les malades soient trait\u00e9s ou non. Il n\u2019y a pas de crainte \u00e0 avoir en ce qui concerne la prise de m\u00e9dicaments antihypertenseurs, y compris les bloqueurs du syst\u00e8me r\u00e9nine-angiotensine. Les premi\u00e8res observations indiquent que le vaccin anti-COVID-19 peut \u00eatre administr\u00e9 chez le malade hypertendu avec la meme efficacit\u00e9 que le normotendu. En conclusion il n\u2019y a pas de raison de prendre en charge le malade hypertendu autrement qu\u2019avant l\u2019apparition de la pand\u00e9mie. <\/jats:p>","DOI":"10.1024\/1661-8157\/a003639","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T05:00:46Z","timestamp":1612328446000},"page":"1-5","source":"Crossref","is-referenced-by-count":0,"title":["CME: L\u2019hypertension art\u00e9rielle et la pand\u00e9mie                     COVID-19: Ce qu\u2019il faut retenir en pratique                     m\u00e9dicale"],"prefix":"10.1024","volume":"110","author":[{"given":"Gr\u00e9goire","family":"Wuerzner","sequence":"first","affiliation":[{"name":"Service de N\u00e9phrologie et Hypertension, CHUV, Lausanne"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Waeber","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de biologie et de m\u00e9decine, Universit\u00e9 de                     Lausanne"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"101","reference":[{"key":"c1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.87.5.e1"},{"key":"c2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa097"},{"key":"c3","doi-asserted-by":"publisher","DOI":"10.1038\/nature00786"},{"key":"c4","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145"},{"key":"c5","first-page":"e205619","volume":"3","author":"Xie J","year":"2020","journal-title":"Clinical characteristics of patients who died of coronavirus disease"},{"key":"c6","first-page":"2052","volume":"323","author":"Richardson S","year":"2020","journal-title":"Presenting characteristics, comorbidities, and outcomes among"},{"key":"c7","first-page":"1574","volume":"323","author":"Grasselli G","year":"2020","journal-title":"Baseline characteristics and outcomes of"},{"key":"c8","doi-asserted-by":"publisher","DOI":"10.1111\/acem.14104"},{"key":"c9","doi-asserted-by":"publisher","DOI":"10.5334\/gh.814"},{"key":"c10","doi-asserted-by":"publisher","DOI":"10.1177\/1470320320926899"},{"key":"c11","author":"Wu Z","year":"2020","journal-title":"Characteristics of and important lessons from the coronavirus disease"},{"key":"c12","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"c13","doi-asserted-by":"publisher","DOI":"10.2196\/20872"},{"key":"c14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.04.021"},{"key":"c15","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glaa183"},{"key":"c16","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2521-4"},{"key":"c17","doi-asserted-by":"publisher","DOI":"10.12.20211722"},{"key":"c18","first-page":"1049","volume":"69","author":"Czeisler ME","year":"2020","journal-title":"30,"},{"key":"c19","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-020-00541-w"},{"key":"c20","first-page":"33325240","volume-title":"Hypertension","author":"Sheppard JP","year":"2020"},{"key":"c21","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.11301"},{"key":"c22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"c23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923"},{"key":"c24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2008975"},{"key":"c25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa433"},{"key":"c26","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2020-317393"},{"key":"c27","author":"Liu Y","year":"2020","journal-title":"medRxiv"},{"key":"c28","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1746200"},{"key":"c29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"c30","first-page":"479","volume":"10","author":"Krittanawong C","year":"2020","journal-title":"Am J Cardiovasc Dis"},{"key":"c31","volume":"107750","author":"Oz M","year":"2020","journal-title":"Pharmacol Ther"}],"container-title":["Praxis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/econtent.hogrefe.com\/doi\/pdf\/10.1024\/1661-8157\/a003639","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,21]],"date-time":"2022-11-21T13:07:21Z","timestamp":1669036041000},"score":1,"resource":{"primary":{"URL":"https:\/\/econtent.hogrefe.com\/doi\/10.1024\/1661-8157\/a003639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1024\/1661-8157\/a003639"],"URL":"https:\/\/doi.org\/10.1024\/1661-8157\/a003639","relation":{},"ISSN":["1661-8157","1661-8165"],"issn-type":[{"value":"1661-8157","type":"print"},{"value":"1661-8165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}